JHVEPhoto Shares of Vivos Therapeutics ( NASDAQ: VVOS ) climbed on Wednesday after MedTech announced the FDA's 510(k) clearance for its DNA appliance as a treatment for children with obstructive sleep apnea (OSA) and snoring. Accordingly, DNA, Vivos' ( VVOS ) flagship oral medical device, will.
Back to Health Page
